Columbia Center for Translational Immunology, Department of Medicine, Columbia University, New York, NY, United States.
Department of Surgery, Columbia University, New York, NY, United States.
Front Immunol. 2021 Nov 5;12:777756. doi: 10.3389/fimmu.2021.777756. eCollection 2021.
Recent advances in high throughput sequencing (HTS) of T cell receptors (TCRs) and in transcriptomic analysis, particularly at the single cell level, have opened the door to a new level of understanding of human immunology and immune-related diseases. In this article, we discuss the use of HTS of TCRs to discern the factors controlling human T cell repertoire development and how this approach can be used in combination with human immune system (HIS) mouse models to understand human repertoire selection in an unprecedented manner. An exceptionally high proportion of human T cells has alloreactive potential, which can best be understood as a consequence of the processes governing thymic selection. High throughput TCR sequencing has allowed assessment of the development, magnitude and nature of the human alloresponse at a new level and has provided a tool for tracking the fate of pre-transplant-defined donor- and host-reactive TCRs following transplantation. New insights into human allograft rejection and tolerance obtained with this method in combination with single cell transcriptional analyses are reviewed here.
近年来,T 细胞受体(TCR)高通量测序(HTS)和转录组分析技术,特别是单细胞水平的转录组分析技术的进步,为深入理解人类免疫学和免疫相关疾病开辟了新的途径。本文讨论了使用 TCR HTS 来识别控制人类 T 细胞库发育的因素,以及如何将这种方法与人类免疫系统(HIS)小鼠模型结合使用,以前所未有的方式理解人类库的选择。人类 T 细胞中有极高比例的具有同种异体反应性,这最好被理解为控制胸腺选择的过程的结果。高通量 TCR 测序允许在新的水平上评估人类同种反应的发展、规模和性质,并提供了一种工具来跟踪移植后移植前定义的供体和宿主反应性 TCR 的命运。本文回顾了使用这种方法与单细胞转录分析相结合获得的关于人类同种异体移植物排斥和耐受的新见解。